Parallax Volatility Advisers, L.P. Biocryst Pharmaceuticals Inc Transaction History

Parallax Volatility Advisers, L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$2.91 - $9.15 $31,137 - $97,905	-10,700 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$6.51 - $9.6 $69,344 - $102,259	10,652 Added 22191.67%	10,700 $86,000
Q3 2018 Nov 14, 2018	BUY	$5.52 - $7.99 $264 - $383	48 New	48 $0
Q1 2018 May 15, 2018	SELL	$4.35 - $5.82 $65,223 - $87,265	-14,994 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$4.16 - $5.33 $62,375 - $79,918	14,994	14,994 $74,000

279

172M

625K

739K

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.31B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.